Abbott (ABT) Reports In-Line Q3 EPS, Offers Q4 Guidance

Abbott (NYSE: ABT) reported Q3 EPS of $0.75, in-line with the analyst estimate of $0.75. Revenue for the quarter came in at $7.7 billion versus the consensus estimate of $7.65 billion.

GUIDANCE:

Abbott sees FY2018 EPS of $2.87-$2.89, versus the consensus of $2.89.

Abbott sees Q4 2018 EPS of $0.80-$0.82, versus the consensus of $0.82.

For earnings history and earnings-related data on Abbott (ABT) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Abbott and NACHC launch nationwide Food for Health initiative to make nutritious food a core part of healthcare
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance